SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:143026762"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:143026762" > Diagnostic Approach...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002830naa a2200553 4500
001oai:prod.swepub.kib.ki.se:143026762
003SwePub
008240415s2020 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1430267622 URI
024a https://doi.org/10.2174/18715303196661908281253162 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Tavakol, M4 aut
2451 0a Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency
264 1b Bentham Science Publishers Ltd.c 2020
520 a Primary immunodeficiency diseases (PIDs) are a group of more than 350 disorders affecting distinct components of the innate and adaptive immune systems. In this review, the classic and advanced stepwise approach towards the diagnosis of PIDs are simplified and explained in detail.Results:Susceptibility to recurrent infections is the main hallmark of almost all PIDs. However, noninfectious complications attributable to immune dysregulation presenting with lymphoproliferative and/or autoimmune disorders are not uncommon. Moreover, PIDs could be associated with misleading presentations including allergic manifestations, enteropathies, and malignancies.Conclusion:Timely diagnosis is the most essential element in improving outcome and reducing the morbidity and mortality in PIDs. This wouldn’t be possible unless the physicians keep the diagnosis of PID in mind and be sufficiently aware of the approach to these patients.
700a Jamee, M4 aut
700a Azizi, G4 aut
700a Sadri, H4 aut
700a Bagheri, Y4 aut
700a Zaki-Dizaji, M4 aut
700a Mahdavi, FS4 aut
700a Jadidi-Niaragh, F4 aut
700a Tajfirooz, S4 aut
700a Kamali, AN4 aut
700a Aghamahdi, F4 aut
700a Noorian, S4 aut
700a Kojidi, HT4 aut
700a Mosavian, M4 aut
700a Matani, R4 aut
700a Dolatshahi, E4 aut
700a Porrostami, K4 aut
700a Elahimehr, N4 aut
700a Fatemi-Abhari, M4 aut
700a Sharifi, L4 aut
700a Arjmand, R4 aut
700a Haghi, S4 aut
700a Zainaldain, H4 aut
700a Yazdani, R4 aut
700a Shaghaghi, M4 aut
700a Abolhassani, Hu Karolinska Institutet4 aut
700a Aghamohammadi, A4 aut
710a Karolinska Institutet4 org
773t Endocrine, metabolic & immune disorders drug targetsd : Bentham Science Publishers Ltd.g 20:2, s. 157-171q 20:2<157-171x 2212-3873x 1871-5303
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:143026762
8564 8u https://doi.org/10.2174/1871530319666190828125316

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view